Abstract. Curcumin has potential anticancer activity and has been shown to be involved in several signaling pathways including differentiation and apoptosis. Our previous study showed that water-soluble PLGA curcumin nanoparticles (Cur-NPs) triggered apoptotic cell death through regulation of the function of MDR1 and the production of reactive oxygen species (ROS) in cisplatin-resistant human oral cancer CAR cells. In this study, we investigated the anti-proliferative effects of Cur-NPs on human osteosarcoma U2OS cells. The morphology of Cur-NPs showed spherical shape by TEM analysis. The encapsulation efficiency of curcumin in Cur-NPs prepared by single emulsion was 90.5±3.0%. Our results demonstrated that the curcumin fragments on the mass spectrum of Cur-NPs and the peaks of curcumin standard could be found on the Cur-NPs spectrum by 1 H-NMR spectra analysis. Cur-NPs induced antiproliferative effects and apoptosis in U2OS cells. Compared to the untreated U2OS cells, more detectable amount of Cur-NPs was found inside the treated U2OS cells. Cur-NPs induced DNA fragmentation and apoptotic bodies in U2OS cells. Both the activity and the expression levels of caspases-3/-7 and caspase-9 were elevated in the treated U2OS cells. Cur-NPs upregulated the protein expression levels of cleaved caspase-3/ caspase-9, cytochrome c, Apaf-1 and Bad and downregulated the protein expression level of p-Akt in U2OS cells. These results suggest Cur-NPs are effective in enhancing apoptosis in human osteosarcoma cells and thus could provide potential for cancer therapeutics.
Introduction
Osteosarcoma is one of the common primary malignant bone tumor diagnosed in children and teenagers (1, 2) . Current chemotherapy regimens of osteosarcoma are based on a combination of doxorubicin, methotrexate (MTX) and cisplatin (3) (4) (5) (6) . Only 50-60% of tumors are chemosensitive, demonstrating the dismal outcome that occurs far too often in osteosarcoma (7) (8) (9) . One potential strategy to overcome known chemotherapy agents in osteosarcoma is to seek out alternative anticancer agents, particularly those appearing from natural products or traditional Chinese medicine (TCM) (10) (11) (12) (13) .
Curcumin is from the plant Curcuma longa (tumeric) and has been used in traditional Chinese medicine for thousands of years (14) (15) (16) (17) (18) . Many pharmacological effects have been reported including anti-amyloid, anti-bacterial, anti-depressant, anti-inflammatory, anti-oxidant and anticancer properties (19) (20) (21) (22) (23) (24) . Curcumin has also been proven to affect multiple signaling pathways such as inhibiting cancer cell proliferation, inducing apoptosis or autophagy (25) (26) (27) , blocking cell invasion and migration (28) (29) (30) (31) and suppressing inflammatory responses (19, (32) (33) (34) . Phase II and III clinical trials with curcumin have advocated its use for patients with colon and pancreatic cancers (35) (36) (37) (38) (39) (40) (41) . The low water solubility contributed to the poor bioavailability is the primary limiting factor for the efficacy and safety of curcumin (42) (43) (44) (45) (46) . To improve the oral bioavailability of curcumin, we designed and developed Cur-NPs (PLGA nanoparticles loaded with curcumin) (Fig. 1A) (42) . The morphology of the Cur-NPs was examined by transmission electron microscopy. The produced Cur-NPs are spherical in shape with smooth surface (Fig. 1B) . Our previous study showed that the Cur-NPs caused anti-proliferation effects on cisplatin-resistant human oral cancer CAR cells, but little cytotoxicity to the normal human gingival fibroblasts cells (HGF) and normal human oral keratinocyte cells (OK) (42) . The aims of this study were to characterize the properties of Cur-NPs and Curcumin-loaded nanoparticles enhance apoptotic cell death of U2OS human osteosarcoma cells through the Akt-Bad signaling pathway to investigate the molecular mechanisms triggered by Cur-NPs in human osteosarcoma U2OS cells. Curcumin loaded nanoparticles. Curcumin-loaded PLGA nanoparticles (Cur-NPs) were prepared by using single emulsion solvent evaporation method. Cucurmin (1 mg) and PLGA (10 mg) were dissolved in dichloromethane. The curcumin and PLGA solution (1 ml) was added to 2 ml of 10% (w/v) PVA surfactant solution to form an oil-in-water emulsion by sonication. The emulsion was carried out by setting sonication at 55 W of energy output for 3 min over an ice bath. The formed emulsion was dispersed by dropping into the 0.5% (w/v) PVA solution and stirred for an additional 4 h at room temperature on a magnetic stir plate to allow evaporation of organic solvent. Nanoparticles were collected by centrifugation at 12,000 rpm for 30 min and washed twice with double distilled water to remove PVA and un-encapsulated curcumin. The prepared nanoparticles were collected and lyophilized (42) .
Materials and methods

Chemicals
Size, polydispersity index (PDI) and encapsulation efficiency.
The size and the polydispersity of prepared nanoparticles (PLGA-NPs and Cur-NPs) were measured using DLS (Zetasizer Nano ZS, 3000HS, Malvern Instruments Ltd., Worcestershire, UK). To determine the encapsulation efficiency in Cur-NPs before freeze-drying, the amount of nonencapsulated curcumin was measured the absorption value of OD 450 nm by ELISA reader. Cell viability and apoptotic morphological features. The cell viability was assessed by the MTT assay. The U2OS cells were cultured in a 96-well plate at the density of 1x10 4 cells per well and were incubated with 0, 0.25, 0.5, 1 and 2 µg/ml of Cur-NPs for 24 and 48 h. Then, culture medium containing 500 µg/ml MTT was added to each well and incubated at 37˚C for 4 h. After incubation, the supernatant was removed. The formed blue formazan crystals in viable U2OS cells were dissolved with isopropanol/0.04 N HCl, followed by measurement of the absorbance of each well at 570 nm with the ELISA reader. All experiments were performed in triplicate. The morphological examination in Cur-NPs-treated U2OS cells was determined under a phase-contrast microscope (50).
Internalization of curcumin.
To track the internalization of Cur-NPs, U2OS cells (1x10 6 ) were seeded on 6-well plates and incubated overnight. Subsequently, cells were treated with 1 µg/ml of Cur-NPs for 24 h. Finally, cells were washed with PBS twice and the internalized curcumin particles were observed under a fluorescence microscope with the filter of 488-nm excitation wavelength and 520-nm emission (27) .
DNA fragmentation assay. The U2OS cells (1x10 7 ) were exposed to 1 µg/ml Cur-NPs for 48 h. Cells were harvested, washed by PBS and then lysed in 500 µl lysis buffer at 4˚C. The lysed cells were digested overnight with proteinase K (100 µg/ml) at 50˚C followed by incubation with 50 µg/ml RNase A at 37˚C for 1 h. DNA fragments were extracted twice with phenol/chloroform/ isopropanol (24:25:1; v/v/v) and precipitated with 50% isopropanol with glycogen (20 µg/ml) before being re-suspended in 100 µl Tris-EDTA (TE) buffer (Amresco Inc., Solon, OH, USA). Samples were electrophoresed on 1.8% (w/v) agarose gel (SigmaAldrich Corp.) in 0.5X TBE buffer (Amresco Inc.) and DNA was stained with 1 µg/ml ethidium bromide (Life Technologies). The gel was observed and photographed under a UV lamp (54, 55) .
Western blot analysis. The U2OS cells (1x10 7 ) were treated with 0, 0.5, 1 and 2 µg/ml of Cur-NPs for 12 or 48 h. Cells were then harvested, lysed and the total proteins were collected by SDS sample buffer. Approximately 50 µg of proteins from each treatment were resolved on 10% SDS-polyacrylamide gel electrophoresis (PAGE) and electro-transferred to the Immobilon-P Transfer Membrane (Merck Millipore). The transferred membranes were blocked with 5% non-fat dry milk in 20 mM Tris-buffered saline/0.05% Tween-20 for 1 h at room temperature followed by incubation with appropriate primary antibodies at 4˚C overnight. At the end of incubation, membranes were washed with Tris-buffered saline/Tween-20 and incubated with secondary antibodies conjugated with HRP. The blots were developed by the chemiluminescence kit and then exposed to X-ray film. Each membrane was stripped and reprobed with anti-β-actin antibody (Sigma-Aldrich Corp.) to ensure equal protein loading during the experiments (47, 56, 57) .
Assays for caspase-3/-7 and caspase-9 activities. The U2OS cells (1x10 7 ) were exposed to 1 µg/ml of Cur-NPs for 0, 12, 24, 36 and 48 h. Subsequently, cells were harvested, and cell lysates were assessed in accordance with the manufacturer's instructions provided in the caspase-3/-7 and caspase-9 colorimetric assay kits (R&D System Inc.). Cell lysate containing 50 µg proteins were then incubated for 1 h at 37˚C with specific caspase-3/-7 substrate (DEVD-pNA) or caspase-9 substrate (LEHD-pNA) and determined by measuring OD 405 of the released pNA (58-60).
Statistical analysis. All the statistical results are performed as the mean ± standard error of the mean (SEM) for the indicated numbers of independent experiments. Statistical analyses of data were done using one-way ANOVA followed by Student's t-test and the levels of P<0.001 was considered significant between the treated and untreated group (61).
Results
Characterization of Cur-NPs. In order to improve the application of curcumin, curcumin was encapsulated by PLGA to form curcumin-loaded PLGA nanoparticles (Cur-NPs) by single emulsion method (Fig. 1A) . The nanoparticle form of curcumin exhibited good water-solubility and formed a transparent solution while dissolving in water. TEM was used to examine the morphology of the Cur-NPs. As shown, the Cur-NPs showed spherical shape (Fig. 1B) . The size distribution of Cur-NPs in aqueous solution was measured by DLS. As shown in Fig. 2A , the size of Cur-NPs is ~250 nm, similar to the curcumin-empty PLGA-NPs. Both nanoparticles showed small polydispersity index (PDI) ( Fig. 2A) , indicating their homogeneous size distribution (Fig. 2B) . The encapsulation efficiency of curcumin in Cur-NPs prepared by single emulsion was 90.5±3.0% ( Fig. 2A) .
In order to confirm that curcumin was unaffected after nano-technologization, mass (MS) spectroscopy of curcumin and Cur-NPs were performed and we found the curcumin fragments on MS spectrum of Cur-NPs (Fig. 3) . Furthermore, the proton nuclear magnetic resonance ( 1 H-NMR) spectroscopy was used to obtain the 1 H-NMR spectra of PLGA-NPs [poly(lactic-co-glycolic acid) nanoparticles], curcumin standard and Cur-NPs (Fig. 4) . Comparing Fig. 4A and B, all the peaks of curcumin standard (Fig. 4A ) could be found on the Cur-NPs spectrum ( Fig. 4B) 
Cur-NPs trigger mitochondria-dependent apoptotic cell death in U2OS cells.
To examine whether Cur-NPs induces apoptosis in U2OS cells, cells were treated with 1 µg/ml of Cur-NPs for 0, 12, 24, 36 and 48 h before subjected to caspase-3/-7 and caspase-9 activities. Cur-NPs stimulated caspase-9 ( Fig. 7A ) and caspase-3/-7 ( Fig. 7B ) activities in Cur-NPs-treated U2OS cells and this effect is time-dependent. Based on these findings, we provide evidence regarding the intrinsic caspase contributing to Cur-NPs-induced apoptosis in U2OS cells.
Mitochondria-dependent and Akt-Bad signaling pathways
were involved in Cur-NPs-induced apoptosis in U2OS cell apoptosis. We examined the effects of Cur-NPs on mitochondria-dependent and Akt-Bad signaling pathways in U2OS cells. The immunoblotting results showed that the protein level of p-Akt was decreased in Cur-NPs-treated U2OS cells (Fig. 8A) . In contrast, the protein levels of cleaved caspase-3, cleaved caspase-9, cytochrome c, Apaf-1 and Bad were increased in Cur-NPs-treated U2OS cells (Fig. 8B) . In conclusion, our data expand the current understanding of Cur-NPs treatment in U2OS cells on causing cell death through the mitochondrial-dependent caspase cascade and the Akt-Bad signaling in vitro. H-NMR spectra of curcumin and Cur-NPs were determined as described in Materials and methods.
Discussion
The study published by Yin et al demonstrated that Cur-NPs are effective in inhibiting the growth of human lung cancer and exhibited little toxicity to normal tissues in an established A549 xenograft mouse model (42, 62) . Our previous study also showed that the Cur-NPs used in our study caused anti-proliferation effects on CAR cells in a dose-and time-dependent manner but little cytotoxicity to the normal human gingival fibroblasts cells (HGF) and normal human oral keratinocyte cells (OK) (29) . This is the first study to investigate the anti-human osteosarcoma effects of Cur-NPs on human osteosarcoma U2OS cells. Our results showed that Cur-NPs inhibited U2OS cell proliferation ( Fig. 5 ) and induced apoptotic cell death (Fig. 6 ) in a concentration-and time-dependent manner. The results in Fig. 7 show Cur-NPs enhanced cell apoptosis through the activation of caspase-9 and caspase-3/-7 in U2OS cells. Our results suggested that Cur-NPs-induced apoptosis might be through the mitochondria-dependent signaling pathway, which has a connection with the activation of caspase-9 and -3.
Previous research has shown that mitochondrial-mediated apoptosis is regulated by the Bcl-2 family proteins (63-65). The Bcl-2 family includes pro-apoptotic proteins (Bax and Bad) and anti-apoptotic proteins (Bcl-2 and Bcl-xL) (66) (67) (68) (69) (70) . The ratio of pro-apoptotic and anti-apoptotic proteins is thought to determine, at least in part, the susceptibility of cells to a death signal (68,69,71) . Previous studies have shown that the apoptotic stimuli can de-phosphorylate Bad and release Bad from the 14-3-3 protein (72-75). Thus, Bad will compete with Bcl-2/Bcl-xL in binding to Bax (76) (77) (78) (79) . Previously, it was shown that functional Akt phosphorylated Bad at Ser136 to promote the stabilization of the mitochondrial membrane system and cell survival (78, 80) . Our results demonstrated that the protein level of p-AKT was decreased (Fig. 8A) , while the protein levels of cleaved caspase-3, cleaved caspase-9, cytochrome c, Apaf-1 and BAD were increased in Cur-NPstreated U2OS cells (Fig. 8B) . The results suggest that Cur-NPs enhance apoptotic cell death of human osteosarcoma U2OS cells through the Akt-Bad signaling pathway.
In conclusion, Cur-NPs induce cell apoptosis in human osteosarcoma U2OS cells. The findings suggest that the major pharmacologic action of Cur-NPs is to trigger apoptotic cell death through activation of caspase-9 and caspase-3/-7 connected to mitochondria-dependent and Akt-Bad signaling pathway in U2OS cells (Fig. 9) . Cur-NPs could be one of the potential compounds to be developed as a novel medicine against human osteosarcoma. 
